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Abstract
Temperature storage requirements 
for medicinal products stored at room 
temperature were compiled.  The rate 
of heat loss in a local pharmacy was 
investigated.  Necessary measures 
required to achieve temperature 
controlled storage conditions in the 
most efficient manner were proposed.  
Energy efficiency together with carbon 
emission reductions were calculated. 
 
Introduction
Pharmaceuticals should be stored 
under conditions recommended by 
the manufacturing company at all 
times to prevent deterioration of the 
product.1 Proper storage ensures that 
medications are safe for their intended 
use, without losing their efficacy or 
causing undue adverse drug reactions.2 
The impact of exposure of medicinal 
products to temperatures which are 
outside room temperature (maximum 
of 25°C) is not well documented.  
Maintaining a community pharmacy 
or a pharmaceutical store at 25°C 
in the local scenario, where during 
summer months the temperature 
is normally above 30°C, requires 
a large investment in temperature 
control mechanisms and an indirect 
environmental impact.  Yet, little is 
known about the impact on specific 
products if they are stored at higher 
temperatures than 25°C limit.
Temperature variations between 
15°C to 30°C may be experienced in 
pharmaceutical storage areas. Provided 
the mean kinetic temperature remains 
in the allowed range, transient spikes 
up to 40°C are permitted only if the 
manufacturer instructs so.3  Stability 
studies show that in periods of heat 
waves, drugs do not deteriorate unless 
the heat wave exceeds the period 
of 6 months.  This is because the 
temperature is not constantly 40°C.3 
Also the temperature reaching the core 
of the drug remains much lower than 
the ambient temperature due to the 
limitation of heat exchange provided by 
packaging material.4
Method
Storage conditions were compiled 
for the medications listed in the 
Marketing Authorisation.5  Information 
regarding the recommended storage 
conditions of these products was 
gathered from published research 
papers,5,6 the respective Summary 
of Product Characteristics and the 
Patient Information Leaflet.  When 
this information was not available, the 
manufacturing company was directly 
contacted for each particular product 
and was asked to provide storage data 
specific for the Maltese climate zone.  
Results and Discussion
Data was collected for 1794 
medications after reviewing SmPC and 
directly from manufacturing companies.  
It resulted that 1039 medications should 
be stored below 25°C, 414 below below 
30°, 4 medications below 37°C and 334 
have no special temperature storage 
conditions. Three medications should not 
be exposed to temperatures above 50°C, 
due to the presence of pressurised gas.
The rate of heat loss in a typical 
Maltese pharmacy was investigated.  A 
pharmacy plan was laid out, depicting 
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A plan of a typical pharmacy was set so that the heat losses could be 
calculated.  This is a 60m2 pharmacy consisting of a main dispensing area 
having an area of 36m2 and 2 stores (12 m2 each).  Both stores have access to 
an external area.  It is assumed that on either side of the pharmacy there are 
third party buildings. Each area is equipped with an efficient air conditioner; 
assumed to be 32.5% efficient.7
figure 1. Pharmacy Plan
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a 60m2 pharmacy area, consisting of a 
main dispensing area and two stores 
linked to the dispensing area through a 
door (Figure 1). Medicines are grouped 
according to the maximum temperature 
storage conditions permitted in the two 
different isolated stores of the pharmacy.
For efficient temperature control, 
an integrated air conditioned system 
could be installed which ensures that 
designated areas have the specific 
recommended temperature conditions 
namely less than 25°C and 30°C 
respectively, reflecting a substantial 
reduction in cooling capacity. 
It is possible to store 1039 different 
medicinal products (stable below 
25°C) in store 1 and in the dispensing 
area. The remaining 755 medications 
(stored below 30°C or have no special 
temperature storage conditions) are 
stored separately in store 2.  The air 
conditioning temperatures should be 
set to 24oC and 29oC respectively, 
ensuring that all medications are 
stored in accordance to their storage 
requirements.
Heat losses could be further 
minimized by installing doors between 
Store 2 (29°C) and the dispensing 
area (24oC). In general for all sections 
of a pharmacy, reduction in cooling 
capacity can be achieved by reducing 
heat losses, using UV blocking double 
glazed doors leading to external areas 
of the pharmacy and air curtains at the 
main entrance if doors are frequently 
left open.  Future considerations include 
roof, floor and wall insulation coatings 
and the use of photovoltaic solar panels.
In a smart pharmacoeconomic 
scenario of segregation of medications 
according to maximal tolerated 
temperatures being a cardinal turning 
point for a reduction in required cooling 
capacity, electrical efficiency and 
reduction in carbon dioxide emissions 
were calculated.  For one pharmacy, 
over €580 and over 3150kg of CO2 
can be saved during the summer 
months (May to September) when 
high temperatures are reached.  These 
figures were worked out on the current 
electricity cost in Malta, where 1 kWh 
costs €0.161 and produces 0.871 kg of 
CO2
.  Taking into consideration all the 
215 pharmacies in the Maltese islands, 
a total of €124,700 can be saved, and 
around 677,250kg of CO2 avoided every 
summer.  
Temperature variations 
between 15°C to 30°C 
may be experienced 
in pharmaceutical storage areas
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